Nigerian firm steps up with HIV and Malaria test kits post US funding cuts

In response to significant funding reductions from US donor agency USAID, Nigerian manufacturer Codix Bio Ltd is set to produce millions of HIV and Malaria test kits. This initiative aims to address critical shortages in the local and regional healthcare markets. The new production facility located outside Lagos represents a pivotal step towards enhancing healthcare accessibility and self-reliance in disease testing across Africa. This development underscores the growing capacity of African nations to tackle health challenges internally, reducing dependency on foreign aid. Keywords: healthcare innovation, disease testing, African manufacturing, self-reliance, health funding.